Mr. Rao, Interim CEO, commented, "We are heartbroken by this unexpected, tragic loss. Pankaj was a respected leader and visionary throughout his ten years at Sonnet. His unwavering belief in Sonnet's technology and dedication to providing much needed treatment options to patients has continued to propel Sonnet to where it is today. Our support and deepest condolences are with his family and loved ones during this extraordinarily sad time." PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherap ...